The global cerebral aneurysm management market size is predicted to generate a market value of US$ 1.56 billion in 2023 and a market value of US$ 2.98 billion by 2023 to 2033, at a CAGR of 6.7%. The rise in the elderly population and the availability of various treatments to treat the ailment might be contributed to the growth of the cerebral aneurysm management market. In the historical period 2018 to 2022, the market for cerebral aneurysm management grew at a CAGR of 4%.
The growth of the cerebral aneurysm treatment market is driven by the increasing number of individuals with cerebrovascular disorders globally. Factors such as a rise in patients with high blood pressure, trauma to blood vessels, and unhealthy lifestyle habits like smoking contribute to the growth of the market. The increasing use of medical therapies for treating un-ruptured intracranial aneurysms, advancements in neurodegenerative disease drug discovery, and an increase in cigarette smokers responsible for brain cancer also play a role.
Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-16634
The improving healthcare infrastructure, increase in healthcare expenditure, and ongoing research and development efforts further boost the market. The market outlook for 2023 to 2033 is favorable, with opportunities for growth due to innovations in drugs and treatment options. Furthermore, North America and Europe are expected to be major contributors for the development of Cerebral aneurysm management market owing to the prevalence of geriatric population and technologically advanced healthcare infastructures.
Key Takeaways from the Market Study
- The Cerebral aneurysm management market is expected to grow at a value of 6.7% CAGR in the forecast period 2023 to 2033.
- By distribution channel, hospital pharmacies are expected to hold 40% of the market share in 2023 for Cerebral aneurysm management market.
- North America is expected to possess 45% market share for Cerebral aneurysm management market in 2023.
- Asia Pacific Cerebral aneurysm management market size is expected to possess 37% market share in 2023.
“Increase in technologically advanced healthcare infrastructures along with awareness of treating Cerebral aneurysm is driving the growth of the Cerebral aneurysm management market.” states an FMI analyst
Talk to Analyst@ https://www.futuremarketinsights.com/ask-question/rep-gb-16634
Competitive Landscape
Key players in the cerebral aneurysm management market are Biogen, Pfizer Inc, Hoffmann-La Roche Ltd, Merck Sharp & Dohme Corp, Novartis AG, Sanofi, Teva Pharmaceutical Industries Ltd., Orion Corporation, UCB S.A., Acadia Pharmaceuticals Inc, Lundbeck A/S, Mitsubishi Tanabe Pharma Corporation
- Sanofi, a key player in the cerebral aneurysm management market is focusing on integrating technology to offer diagnostic test for treating cerebral aneurysm.
- Biogen, another key player in the cerebral aneurysm management market is focusing on investing in research and development for innovating medications.
Key Segments Profiled in the Cerebral Aneurysm Management Market Survey
Drug Class:
- Antihypertensives
- Antiepileptics
- Analgesics
- Antiemetics
- Antacids
Route of Administration:
- Oral
- Injectable
- Transdermal
Distribution Channel:
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Buy Now@ https://www.futuremarketinsights.com/checkout/16634
About the Healthcare at Future Market Insights
The healthcare domain team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 Billion+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.
About Future Market Insights, Inc.
Future Market Insights, Inc. is an ESOMAR-certified business consulting & market research firm, a member of the Greater New York Chamber of Commerce and is headquartered in Delaware, USA. A recipient of Clutch Leaders Award 2022 on account of high client score (4.9/5), we have been collaborating with global enterprises in their business transformation journey and helping them deliver on their business ambitions. 80% of the largest Forbes 1000 enterprises are our clients. We serve global clients across all leading & niche market segments across all major industries.
Contact:
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs